Actions Against Physician Licenses Due to Substance Use Down
However, despite declines from 2004 to 2020, substance use-related actions remain much higher than actions for physical, psychological impairment
Addiction/dependence
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis
During Pandemic, Growth of Clinicians With X-Waivers for Buprenorphine Prescribing Slowed
Survey of 126 clinicians helps pinpoint barriers to obtaining waivers, prescribing buprenorphine
Buprenorphine Underused for OUD, Particularly Polysubstance Use
Yet, study shows buprenorphine is effective in protecting against overdose in this population
CDC: Overdose Deaths Up 15% in 2021
However, growth in overdose deaths has slowed compared with the 30 percent increase seen in 2020
White House Releases Detailed Plan to Tackle the Overdose Epidemic
The Strategy focuses on 2 main drivers of the opioid epidemic: drug trafficking and untreated addiction.
Buprenorphine Prescribing for Medicaid Beneficiaries Down in 2020
Despite increases in units per prescription, the amount of buprenorphine dispensed to Medicaid beneficiaries decreased early in the pandemic
State Laws Linked to Very Small Changes in Opioid Prescribing
Thirteen state laws each linked to change of less than 1 percent in proportion of patients receiving any opioid prescription
FDA Issues Draft Guidance on Nonopioid Analgesic Drug Development
The FDA defines acute pain as pain, lasting up to 30 days, typically in response to some form of tissue injury, such as trauma or surgery.
Father Sues Pharmacy After Son Overdoses on Illegally Obtained Prescription
The in pari delicto doctrine precludes plaintiffs from recovering damages if their cause of action is based, at least partially, on their own illegal conduct.
